tiprankstipranks

BeiGene price target lowered to $222 from $304 at TD Cowen

TD Cowen lowered the firm’s price target on BeiGene to $222 from $304 and keeps an Outperform rating on the shares. The firm said in conjunction with their Q3 earnings preview they are updating their model to account for anticipated negative impacts from Chinese anti-corruption efforts in Q3 and Q4 and long-term uncertainties surrounding the Chinese market.

Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>

See Insiders’ Hot Stocks on TipRanks >>

Read More on BGNE:

Disclaimer & DisclosureReport an Issue